Back to top of page

The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)

- Name of the organization or individual applying for the grant

- Contact information for the applicant (address, phone number, email)

- Project title (Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers)

- Purpose of the project (advancing hematopoietic cell transplantation for patients with rare and difficult to treat non-malignant blood diseases and hematological malignancies)

- Description of the project (supporting a clinical trials network to evaluate novel cell therapy and HCT approaches)

- Need for a Data Coordinating Center (DCC) and core clinical sites

- Planned funding sources (funds requested as part of this initiative, collaborations with R01-funded grantees, industry, and foundations)

- Factors contributing to the longer duration of most HCT and CT trials (rare patient populations, complex cell manufacturing processes, composite endpoints)

- Duration of the program (seven years)

- Any additional information or documentation required by the grant application process

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows